| 摘要 |
The present invention discloses a new polypeptide- human L1 retroposon 22, the polynucleotide encoding it and a method producing the polypeptide by recombinant DNA technology. The present invention further discloses a method using the polypeptide to treat various disorders, e.g. Duchenne muscular dystrophy, malignant neoplasm, hematopathy, developmental disorder, HIV infection and immunological disease and various inflammation etc.. The present invention also discloses an antagonist of the polypeptide and its therapeutic use. The present invention further discloses the use of the polynucleotide encoding the new human L1 retroposon 22.
|
